Ozanimod is used in trials studying the treatment of Crohn's Disease, Ulcerative Colitis, Multiple Sclerosis, and Relapsing Multiple Sclerosis. It is an investigational immunomodulatory drug.Reference standards of Ozanimod API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Ozanimod
Catalogue No.:PA 15 75000
CAS :
Molecular Formula : C23H24N4O3
Molecular Weight : 404.47
(S)-2-Isopropoxy-5-(3-(1-((2-oxoethyl)amino)-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
Catalogue No.:PA 15 75510
Molecular Formula : C23H22N4O3
Molecular Weight : 402.45
2-Isopropoxy-5-(3-(1-oxo-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile
Catalogue No.:PA 15 0751000
Molecular Formula : C21H17N3O3
Molecular Weight : 359.39
5-(3-(1-Hydroxy-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-isopropoxybenzonitrile
Catalogue No.:PA 15 0751001
Molecular Formula : C21H19N3O3
Molecular Weight : 361.4
Ozanimod N-Formyl Impurity
Catalogue No.:PA 15 0751002
Molecular Formula : C24H24N4O4
Molecular Weight : 432.48
Ozanimod R Isomer
Catalogue No.:PA 15 0751003
(S)-N-(4-(5-(3-Cyano-4-isopropoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-N-(2-hydroxyethyl)nitrous amide
Catalogue No.:PA 15 0751004
Molecular Formula : C23H23N5O4
Molecular Weight : 433.47
Ozanimod-d6
Catalogue No.:PA STI 089611
Molecular Formula : C23H18D6N4O3
Molecular Weight : 410.51
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....